Events

Rappel de Device Recall ETIABAUK PLUS

Selon U.S. Food and Drug Administration, ce/cet/cette rappel concerne un dispositif en/au/aux/à United States qui a été fabriqué par Diasorin Inc..

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • ID de l'événement
    57937
  • Classe de risque de l'événement
    Class 2
  • Numéro de l'événement
    Z-1744-2011
  • Date de mise en oeuvre de l'événement
    2010-08-19
  • Date de publication de l'événement
    2011-03-22
  • Statut de l'événement
    Terminated
  • Pays de l'événement
    United States
  • Date de fin de l'événement
    2012-08-16
  • Source de l'événement
    USFDA
  • URL de la source de l'événement
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=97783
  • Notes / Alertes
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notes supplémentaires dans les données
    Test, hepatitis b (b core, be antigen, be antibody, b core igm) - Product Code LOM
  • Cause
    Through internal testing, diasorin has become aware that the kit lots identified (eti-ab-auk plus kits, catalog number p001931, lot numbers 0650270a and/or 0650270a/1) may not consistently exhibit stability to defined expiration dating, resulting in decreased binding and lower absorbance. internal testing has confirmed that when defined assay validation criteria pass, analytical performance is co.
  • Action
    The firm, DiaSorin, sent a "Customer Notification Letter" dated 19 August, 2010 to its customers. The letter described the product, problem and actions to be taken. The customers were instructed to destroy all remaining inventory and complete and return the receipt of notification and destruction of product form, found in the bottom portion of the letter, via fax to: (651) 351-5669, ATTN: TECHNICAL SERVICES or mail to: ATTN: TECHNICAL SERVICES, 1951 Northwestern Ave., Stillwater, Minnesota 55082-0285. If you have any questions or concerns, please contact DiaSorin Inc., Technical Services at 1-800-328-1482 or 651-439-9710.

Device

Device Recall ETIABAUK PLUS
  • Modèle / numéro de série
    lot numbers 0650270A and 0650270A/1.
  • Classification du dispositif
    Immunology and Microbiology Devices
  • Classe de dispositif
    3
  • Dispositif implanté ?
    No
  • Distribution
    Worldwide distribution: USA including states of: AL, AR, CA, CT, DE, DC, FL, GA, IL, IA, KY, LA, MD, MA, MI, MN, MO, NH, NJ, NM, NY, NC, ND, OH, OK OR, PA, TX, VT, VA, WA,and WI; and country of: SOUTH KOREA.
  • Description du dispositif
    ETI-AB-AUK PLUS kits,REF P001931, DiaSorin S.p.A., 13040 Saluggia (VC), Italy, Distributed by: DiaSorin Inc., 1951 Northwestern Avenue, P.O. Box 285, Stillwater, MN 55082-0285 || In vitro enzyme immunoassay (EIA) intended for use in the qualitative detection of antibodies to hepatitis B surface antigen (anti-HBs) in human serum or plasma.
  • Manufacturer
    Diasorin Inc.

Manufacturer

Diasorin Inc.
  • Adresse du fabricant
    Diasorin Inc., 1951 Northwestern Ave S, Stillwater MN 55082-7536
  • Société-mère du fabricant (2017)
    DiaSorin SpA
  • Source
    USFDA